A detailed history of Cloud Alpha Capital Management Limited transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Cloud Alpha Capital Management Limited holds 40,000 shares of NTLA stock, worth $617,200. This represents 0.04% of its overall portfolio holdings.

Number of Shares
40,000
Holding current value
$617,200
% of portfolio
0.04%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.17B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Cloud Alpha Capital Management Limited Portfolio

Follow Cloud Alpha Capital Management Limited and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cloud Alpha Capital Management Limited, based on Form 13F filings with the SEC.

News

Stay updated on Cloud Alpha Capital Management Limited with notifications on news.